A practical guide to GLP-1 therapy, metabolic health, and long-term population health planning.
eMed delivers a comprehensive program that provides eligible employees access to GLP-1 medications alongside ongoing clinical support. Designed to support adherence and long-term outcomes, this is not a one-time prescription. It is a structured, clinically supported program built for population health.


Affecting costs, productivity, and outcomes on a daily basis.
Employers are facing rising medical claims, increased absenteeism, and growing pressure to offer effective health solutions that deliver real results.
Employees enroll through a streamlined intake process and complete an at-home lab screening.
Licensed clinicians review results and manage GLP-1 prescriptions when appropriate.
Eligible employees receive continuous clinical support, education, and progress tracking to support adherence and safety.
Employers receive aggregated insights into participation, engagement, and outcomes.
Clinical data confirms average weight reduction and high program retention over six months.*